Medgate Today - February/March 2016
English | 77 pages | True PDF | 17.8 MB
English | 77 pages | True PDF | 17.8 MB
The glioblastoma treatment market will increase fivefold from $659 million in 2014 to $3.3 billion by 2024, representing
a rapid Compound Annual Growth Rate (CAGR) of 17.4%, according to research and consulting firm GlobalData.
The company’s latest report* states that this meteoric rise,